Firbas, Christa <br/><br/>
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.  [electronic resource] 

 -  Vaccine  May 2006 
 - 4343-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2006.03.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Hepatitis C--prevention & control<br/>Humans<br/>Interferon-gamma--biosynthesis<br/>Middle Aged<br/>Placebos<br/>Reference Values<br/>Single-Blind Method<br/>T-Lymphocytes--metabolism<br/>Viral Vaccines--adverse effects